Your session is about to expire
← Back to Search
CPAP Machine
CPAP for Polycystic Ovary Syndrome
N/A
Waitlist Available
Led By David A Ehrmann, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
This trial looks at the effects of sleep problems on metabolism and hormones in women with PCOS.
Eligible Conditions
- Polycystic Ovary Syndrome
- Obstructive Sleep Apnea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
3Treatment groups
Experimental Treatment
Group I: 3Experimental Treatment1 Intervention
Randomized to receive CPAP (continuous positive airway pressure) treatment for 6 weeks.
Group II: 1BExperimental Treatment1 Intervention
Randomized to receive depot Lupron for 6 weeks. Then randomized again to receive progesterone plus placebo for another 6 weeks.
Group III: 1AExperimental Treatment1 Intervention
Randomized to receive depot Lupron for 6 weeks. Then randomized again to receive estrogen plus placebo for another 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CPAP
2013
Completed Phase 3
~5460
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,053 Previous Clinical Trials
758,994 Total Patients Enrolled
1 Trials studying Polycystic Ovary Syndrome
37 Patients Enrolled for Polycystic Ovary Syndrome
Duke UniversityOTHER
2,451 Previous Clinical Trials
2,971,679 Total Patients Enrolled
2 Trials studying Polycystic Ovary Syndrome
154 Patients Enrolled for Polycystic Ovary Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,049 Previous Clinical Trials
2,731,065 Total Patients Enrolled
35 Trials studying Polycystic Ovary Syndrome
5,767 Patients Enrolled for Polycystic Ovary Syndrome
Share this study with friends
Copy Link
Messenger